Podcasts
Rest your eyes or use your commute time to learn. Listen to our experts discuss the hot topics that you need to track. And get a glimpse into the personalities behind the smiles.
Featured Content
E3 – Avalere Insights on Recent CMS Proposed Payment Rules: ESRD PPS and Quality Incentive Program
Tune in to hear the final episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 3, we’ll be focusing on the End Stage Renal Disease (ESRD) Prospective Payment System, with a focus on proposed payment changes for innovative drugs, supplies, and equipment and updates to the Quality Incentive Program (QIP).
E2 – Avalere Insights on Recent CMS Proposed Payment Rules: MPFS
Tune in to hear the second episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 2, we’ll be focusing on the Medicare Physician Fee Schedule proposed rule, or MPFS, with a focus on proposed changes to E/M and Opioid Use Disorder (OUD) treatment services.
E1 – Avalere Insights on Recent CMS Proposed Payment Rules: OPPS
Tune in to hear the first episode in our 3-part series that focuses on CMS’s most recent proposed payment rules. In episode 1, we’ll be focusing on the outpatient prospective payment system proposed rule, more informally known as the OPPS.
E4 – Recommendations for How to Overcome Common Barriers When Implementing Cost-of-Care Conversations
Tune in to hear the last episode in our 4-part series that provides clinicians with recommendations for how to overcome common barriers when implementing cost-of-care (CoC) conversations. Peter Ubel will talk with Avalere’s Katherine Steinberg on actionable tips that primary care clinicians can use to help address potential barriers and challenges related to implementing CoC conversations in the clinical setting. Support for this podcast was provided by the Robert Wood Johnson Foundation and the New York State Health Foundation (NYSHealth). The views expressed here do not necessarily reflect the views of the foundations.
E3 – A Guide to Integrating Cost-of-Care Conversations into Workflow
Tune in to hear the third episode in our 4-part series that provides clinicians with actionable approaches for integrating cost-of-care conversations into workflow. Nora Henrikson will talk with Avalere’s Katherine Steinberg on 3 pathways that clinicians can use to best integrate cost of care conversations into their clinical workflows. Support for this podcast was provided by the Robert Wood Johnson Foundation and the New York State Health Foundation (NYSHealth). The views expressed here do not necessarily reflect the views of the foundations.
Critical Steps for Post-Acute Care Organizations to Succeed in Value-Based Care
Tune in as Avalere experts interview each other on hot topics in healthcare. In this discussion, Avalere Managing Director of Health Plans and Providers, Fred Bentley is interviewed by Alexa Trost, Associate, on the current state of value-based care across the health care landscape and critical steps post-acute care organizations needs to take to to succeed in this environment.
E2 – Quick Tips for Clinicians on How to Talk with Patients About the Expected Costs of Care
Tune in to hear the second episode in our 4-part series that provides clinicians with actionable tips and a simple framework for how to structure cost-of-care (CoC) conversations with their patients. Susan Perez and Maria Pisu will talk with Avalere’s Katherine Steinberg on strategies that clinicians can use to discuss costs with their patients. Support for this podcast was provided by the Robert Wood Johnson Foundation and the New York State Health Foundation (NYSHealth). The views expressed here do not necessarily reflect the views of the foundations.
The Growing Role of Digital Health and How It’s Shaping Patient Engagement
Tune in as Avalere experts interview each other on hot topics in healthcare. In this discussion, Avalere Consultant, Priya Gaur is interviewed by Camille Boler, Associate, on the increasing role of digital health and how it's influencing patient engagement.
E1 – Why Should Primary Care Clinicians Routinely Talk with Their Patients About the Expected Costs of Care?
Tune in to hear the first episode in our 4-part series that focuses on how clinicians and other care team members can improve the quality and frequency of cost-of-care (CoC) conversations. To kick-off this series, Gwen Darien and Jim Hardee, will talk with Avalere’s Katherine Steinberg on why clinicians should speak with their patients about the expected costs of their care. Support for this podcast was provided by the Robert Wood Johnson Foundation and the New York State Health Foundation (NYSHealth). The views expressed here do not necessarily reflect the views of the foundations.
Key Takeaways on the Ruling Declaring the Affordable Care Act Unconstitutional
Listen to Avalere experts discuss the implications for a recent decision ruling the Affordable Care Act is Unconstitutional.
E2 – 8 Rules for Implementing New Medicare Advantage Supplemental Benefits
Check out the second episode of our series on new supplemental benefits offered through Medicare Advantage plans for 2019 where Kenny Kan and Erica Breese discuss the "rule of 8".
E3 – Trends in Health Policy and the Mid-Term Elections Results
Tune in to the last episode of our mid-term elections series to hear Avalere experts Chris Sloan and Elizabeth Carpenter discuss potential implications on health policy.
E2 – Key Mid-Term Elections Driving Medicaid Expansion to Watch
Tune in for episode 2 of our mid-term elections podcast. Avalere experts, Chris Sloan and Tiernan Meyer, discuss potential state and federal-level scenarios for Medicaid expansion.
E1 – Impacts the Mid-Term Elections Could Have on Pre-Existing Conditions
Tune in to hear the first episode in our 3-part series covering the mid-term elections and potential implications on health policy. Avalere expert, Chris Sloan, discusses potential implications of the mid-term elections on health policy. To kick off the series Avalere Founder, Dan Mendelson, covers pre-existing conditions.
E1 – New Supplemental Benefits Offered Through Medicare Advantage Plans
In episode 1 of our series Fred Bentley, Sean Creighton, and Kenny Kan discuss the new supplemental benefits offered through Medicare Advantage plans for 2019.
E3 – New Appropriate Use Criteria Increases Likelihood of Accurate Diagnosis for Alzheimer’s Disease
Tune in to our podcast series where guest presenters explore the value of the newly released Alzheimer’s Association appropriate use criteria for lumbar puncture and cerebral spinal fluid (CFS) testing in the diagnosis of Alzheimer’s disease. Dr. Steven Salloway, Director of Neurology and the Memory and Aging Program at Butler Hospital, discusses how the Alzheimer’s Association’s new appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease will be helpful to clinicians in the diagnostic process.
E2 – CSF Clinical Diagnosis’ Used to Inform Guidance on Detecting Alzheimer’s Disease
Tune into the second podcast in our series where Dr. Leslie Shaw, Professor of Pathology and Laboratory Medicine at the Pearlman School of Medicine at the University of Pennsylvania and Chair of the Workgroup that developed the Alzheimer’s Association’s appropriate use criteria for lumbar puncture and cerebral spinal fluid (CSF) testing in the diagnosis of Alzheimer’s disease, discusses how the Workgroup reviewed an extensive body of research on advances in CSF testing to develop the AUC.
E1 – New Appropriate Use Criteria in Diagnosing Alzheimer’s Disease
Tune in to our podcast series as we explore the value of the newly released Alzheimer’s Association appropriate use criteria for lumbar puncture and cerebral spinal fluid (CFS) testing in the diagnosis of Alzheimer’s disease. We kick off this series with Dr. Maria Carillo, the Alzheimer Association’s Chief Science Officer and Dr. Jim Hendrix, Director of Global Science Initiatives.
E3 – Real-World Evidence: Is It a Game Changer for the FDA?
Tune in to the final podcast in our series as we discuss 3 steps companies should complete now to take advantage of the FDA’s priority to advance the adoption of RWE to support agency decision-making.
E2 – Real-World Evidence: Is It a Game Changer for the FDA?
Tune in to episode 2 of our discussion covering why the FDA is so interested in real-world evidence and how they are approaching it.